Aurinia Pharmaceuticals Inc (AUPH)

[Zeppo]

I am a bit miffed at Zack's obvious lack of understanding of biotech. I think it has a universal company analysis form that it uses regardless of the industry it covers. Analysts have forgotten that this product was not approved until late January. Product launches/rollouts are the penultimate results of successful FDA product reviews. No launch is inexpensive, and no launch happens overnight. We're four months, at best, into this process.